Joost P. H. Drenth

Journal of Hepatology · 2013–2021

A researcher in the Science corpus: 5 papers; trusts 0 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Whom Joost P. H. Drenth trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. N. Chalasani

Papers from Joost P. H. Drenth's perspective

Ordered by how strongly the researchers Joost P. H. Drenth trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Simplified criteria for the diagnosis of autoimmune hepatitis (Hepatology)
  2. Autoimmune hepatitis/sclerosing cholangitis overlap syndrome in childhood: A 16‐year prospective study (Hepatology)
  3. The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the… (American Journal of Gastroenterology)
  4. ENDPOINTS AND CLINICAL TRIAL DESIGN FOR NONALCOHOLIC STEATOHEPATITIS (Hepatology)
  5. Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study. (The Lancet)
  6. Liver Fibrosis, but no Other Histologic Features, Associates with Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease (Gastroenterology)
  7. Long‐term follow‐up of patients with NAFLD and elevated liver enzymes (Hepatology)
  8. Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States. (Gastroenterology)
  9. Systematic review: the epidemiology and natural history of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in adults (Alimentary Pharmacology and Therapeutics)
  10. Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial (The Lancet)

Their papers